APA (7th ed.) Citation

Anker, M. S., Lück, L. C., Khan, M. S., Porthun, J., Hadzibegovic, S., Lena, A., . . . von Haehling, S. (2025). New cardiovascular biomarkers in patients with advanced cancer – A prospective study comparing MR‐proADM, MR‐proANP, copeptin, high‐sensitivity troponin T and NT‐proBNP. European Journal of Heart Failure, 27(6), 1047. https://doi.org/10.1002/ejhf.3497

Chicago Style (17th ed.) Citation

Anker, Markus S., et al. "New Cardiovascular Biomarkers in Patients with Advanced Cancer – A Prospective Study Comparing MR‐proADM, MR‐proANP, Copeptin, High‐sensitivity Troponin T and NT‐proBNP." European Journal of Heart Failure 27, no. 6 (2025): 1047. https://doi.org/10.1002/ejhf.3497.

MLA (9th ed.) Citation

Anker, Markus S., et al. "New Cardiovascular Biomarkers in Patients with Advanced Cancer – A Prospective Study Comparing MR‐proADM, MR‐proANP, Copeptin, High‐sensitivity Troponin T and NT‐proBNP." European Journal of Heart Failure, vol. 27, no. 6, 2025, p. 1047, https://doi.org/10.1002/ejhf.3497.